Patent to Pfizer could delay Indian vaccines for pneumonia
https://www.sathguru.com/news/wp-content/uploads/2017/09/12th-September-2017_BusinessStandard__Mumbai.pdf Source: Business Standard
Browsing Tag
PCV
‘We have to create an ecosystem where companies are encouraged to constantly pursue next…
According to a white paper by Sathguru Management Consultants in association with CII on vaccines, India is at the cusp of a new era in vaccines as there is a need for self-financing of immunisation programme in the near future. Pushpa…
What is the way forward for Indian vaccine industry?
While Indian vaccine producers dominate global market, bulk of marketshare in the high-value domestic private market is held by a few MNCs, says Pushpa Vijayraghavan and Aparna Balasubramanian Allaying the threat of preventable deaths,…
Pneumonia vaccine: the new battleground for Indian drug makers
The market for PCVs is huge, there is enough room for at least five entities, said Pushpa Vijayaraghavan, vice-president of consulting firm Sathguru Inc. In India, there are 25 million babies born every year. Even by the most conservative…